Irinotecan and Temozolomide Combined with Dasatinib and Rapamycin for Patients with Relapsed or Refractory Neuroblastoma: Results of the Prospective Randomized RIST TrialSelim Corbacioglu,Holger N. Lode,Marcus Jakob,Meinolf Suttorp,Gabriele Escherich,Bernd Gruhn,Susanne Ellinger,Thorsten Simon,Peter Lang,Marius Rohde,Florian Zeman,Klaus-Michael Debatin,Andreas Beilken,Peter Heiss,Dirk Hellwig,Markus Riemenschneider,Ruth Lydia Ladenstein,Konrad Bochennek,Angelika Eggert,Juergen FoellJOURNAL OF CLINICAL ONCOLOGY（2023）引用 0|浏览32AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
